We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+10.18%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$810M
AUM Growth
+$195M
Cap. Flow
+$133M
Cap. Flow %
16.42%
Top 10 Hldgs %
49.65%
Holding
195
New
66
Increased
84
Reduced
25
Closed
9
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
126
ASML
ASML
$651B
$358K 0.04%
655
+4
+0.6% +$2.1K
TXN icon
127
Texas Instruments
TXN
$236B
$347K 0.04%
2,099
WFC icon
128
Wells Fargo
WFC
$262B
$346K 0.04%
+8,384
New +$371K
ITW icon
129
Illinois Tool Works
ITW
$79.8B
$345K 0.04%
+1,568
New +$334K
DSI icon
130
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$344K 0.04%
4,798
VZ icon
131
Verizon
VZ
$208B
$344K 0.04%
+8,742
New +$329K
SCHH icon
132
Schwab US REIT ETF
SCHH
$11.3B
$344K 0.04%
17,830
+536
+3% +$10.3K
PSTX
133
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$330K 0.04%
+62,347
New +$285K
TMUS icon
134
T-Mobile US
TMUS
$195B
$326K 0.04%
2,327
INTC icon
135
Intel
INTC
$473B
$324K 0.04%
12,273
+178
+1% +$4.94K
ABT icon
136
Abbott
ABT
$195B
$324K 0.04%
+2,950
New +$305K
AES icon
137
AES
AES
$10.5B
$323K 0.04%
11,216
AVGO icon
138
Broadcom
AVGO
$1.75T
$322K 0.04%
5,760
+270
+5% +$13.5K
EFAV icon
139
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.49B
$320K 0.04%
+5,039
New +$308K
NKE icon
140
Nike
NKE
$58.7B
$315K 0.04%
+2,693
New +$271K
TT icon
141
Trane Technologies
TT
$98.8B
$315K 0.04%
+1,874
New +$309K
WEC icon
142
WEC Energy
WEC
$34.6B
$304K 0.04%
+3,246
New +$300K
VRTX icon
143
Vertex Pharmaceuticals
VRTX
$137B
$302K 0.04%
+1,045
New +$318K
T icon
144
AT&T
T
$178B
$298K 0.04%
+16,169
New +$289K
LLY icon
145
Eli Lilly
LLY
$1.05T
$297K 0.04%
+812
New +$288K
UBER icon
146
Uber
UBER
$161B
$296K 0.04%
+11,953
New +$327K
SPGI icon
147
S&P Global
SPGI
$131B
$293K 0.04%
+874
New +$288K
IEMG icon
148
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
$288K 0.04%
6,174
-2,364
-28% -$108K
NVO
149
Novo Nordisk
NVO
$202B
$287K 0.04%
4,244
+200
+5% +$11.7K
CVX icon
150
Chevron
CVX
$396B
$280K 0.03%
+1,562
New +$273K

Similar funds

Callan Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Callan Capital held 195 positions worth $810M, up 32% from $614M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Callan Capital deployed $133M of net new capital in Q4 2022, opening 66 new positions and adding to 84 existing holdings. Its largest new stake was Home BancShares: 247,233 shares worth $5.63M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Dimensional International Small Cap Value ETF, an estimated $15.5M trimmed.

  • Callan Capital's largest Q4 2022 buy was Home BancShares: 247,233 shares worth $5.63M.
  • Callan Capital added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $27.8M increase.
  • Callan Capital's biggest Q4 2022 reduction was Dimensional International Small Cap Value ETF, cutting an estimated $15.5M.
  • Callan Capital fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q4 2022, selling an estimated $1.4M.
  • Callan Capital's ten largest holdings make up 50% of its $810M portfolio in Q4 2022.
  • Callan Capital opened 66 new positions and closed 9 in Q4 2022.
  • Callan Capital's portfolio value rose 32% quarter-over-quarter to $810M.

Based on Callan Capital's 13F filing for Q4 2022, filed 13 Feb 2023.